Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Enzalutamide Monotherapy for the Treatment of Prostate Cancer with High-Risk Biochemical Recurrence: EMBARK Secondary End Points: Erratum.
Journal: The Journal of urology
Published: July 09, 2026
Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points.
Journal: The Journal of urology
Published: December 05, 2025
Prospective Trial of Water Vapor Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia in Subjects with a Large Prostate: 6- and 12-month Outcomes.
Journal: European urology open science
Published: October 19, 2023
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer.
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer.
Journal: Urologic oncology
Published: April 23, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
Journal: European urology oncology
Published: April 19, 2023
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results.
Journal: World journal of urology
Published: November 05, 2019
Development and evaluation of the MiCheck test for aggressive prostate cancer.
Journal: Urologic oncology
Published: October 14, 2019
A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trial.
Journal: Urologic oncology
Published: October 14, 2019
The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial.
Journal: European urology
Published: August 15, 2019
Discovery of the Long Interspersed Nuclear Element-1 activation product [Open Reading Frame-1 (ORF1) protein] in human blood.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: August 16, 2018
Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement.
Journal: World journal of urology
Published: September 12, 2017
A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.
Journal: European urology
Published: July 30, 2014
Last Updated: 09/26/2026